Open interconnected model of basal ganglia-thalamocortical circuitry and its relevance to the clinical syndrome of Huntington's disease

Movement Disorders

Volumn 16, Issue 3, 2001, Pages 407-423

  Joel, D ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Affective disorder; Basal ganglia; Cognitive symptoms; Huntington's disease; Motor symptoms; Parkinson's disease; Psychiatric symptoms

Indexed keywords

BASAL GANGLION; BRADYKINESIA; BRAIN FUNCTION; CHOREA; CLINICAL FEATURE; COGNITIVE DEFECT; CORPUS STRIATUM; DISEASE COURSE; DISEASE SEVERITY; EYE MOVEMENT DISORDER; HUMAN; HUNTINGTON CHOREA; MENTAL DISEASE; MOOD DISORDER; MOTOR DYSFUNCTION; NONBIOLOGICAL MODEL; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY; THALAMOCORTICAL TRACT;

ANIMALS; BASAL GANGLIA; CEREBRAL CORTEX; COGNITION; EMOTIONS; GLOBUS PALLIDUS; HUMANS; HUNTINGTON DISEASE; LIMBIC SYSTEM; MODELS, NEUROLOGICAL; MOVEMENT; NERVE NET; PARKINSON DISEASE; RATS; THALAMUS;

EID: 0035353742     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.1096     Document Type: Review

References (207)

1. Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989;12:366-375.
2. Alexander GE, Crutcher MD. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 1990;13:266-271.
3. Alexander GE, Crutcher MD, Delong MR. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Prog Brain Res 1990;85: 119-146.
4. DeLong MR, Georgopoulos AP. Motor functions of the basal ganglia. In: Brookhart JM, Mountcastle VB, Brooks VB, editors. Hanbook of physiology. Bethseda: American Physiological Society; 1981. p 1017-1061.
5. DeLong MR, Wichmann T. Basal ganglia-thalamocortical circuits in parkinsonian signs. Clin Neurosci 1993;1:18-26.
6. Goldman-Rakic PS, Selemon LD. New frontiers in basal ganglia research. Trends Neurosci 1990;13:241-244.
7. Gray JA, Feldon J, Rawlins JNP, Hemsley DR, Smith AD. The neuropsychology of schizophrenia. Behav Brain Sci 1991;14:1-84.
8. Graybiel AM. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci 1990;13:244-254.
9. Groenewegen HJ, Berendse HW, Wolters JG, Lohman AHM. The anatomical relationship of the prefrontal cortex with the striatopallidal system, the thalamus and the amygdala: evidence for a parallel organization. Prog Brain Res 1990;85:95-118.
10. Groenewegen HJ, Berendse HW. Anatomical relationships between the prefrontal cortex and the basal ganglia in the rat. In: Thierry A-M, Glowinski J, Goldman-Rakic P, Christen Y, eds. Motor and cognitive functions of the prefrontal cortex. Springer-Verlag: Fondation IPSEN; 1994:51-77.
11. Marsden CD. The mysterious motor function of the basal ganglia. Neurology 1982;32:514-539.
12. Marsden CD. Movement disorders and the basal ganglia. Trends Neurosci 1986;9:512-515.
13. Marsden CD, Obeso JA. The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease. Brain 1994;117:877-897.
14. Parent A. Extrinsic connections of the basal ganglia. Trends Neurosci 1990;13:254-258.
15. Penney JB, Young AB. Speculations on the functional anatomy of basal ganglia disorders. Ann Rev Neurosci 1983;6:73-97.
16. Penney JB, Young AB. Striatal inhomogeneities and basal ganglia function. Mov Disord 1986;1:3-15.
17. Swerdlow NR, Koob GF. Dopamine, schizophrenia, mania and depression: toward a unified hypothesis of cortico-striato-pallidothalamic function. Behav Brain Res 1987;10:215-217.
18. Alexander GE, Delong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Ann Rev Neurosci 1986;9:357-381.
19. Joel D, Weiner I. The organization of the basal ganglia-thalamocortical circuits: open interconnected rather than closed segregated. Neuroscience 1994;63:363-379.
20. DeLong MR, Crutcher MD, Georgopoulos AP. Primate globus pallidus and subthalamic nucleus: functional organization. J Neurophysiol 1985;53:530-543.
21. Joel D, Weiner I. The connections of the primate subthalamic nucleus: Indirect pathways and the open-interconnected scheme of basal ganglia-thalamocortical circuitry. Brain Res Brain Res Rev 1997;23:62-78.
22. Joel D, Weiner I. The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum. Neuroscience 2000;96:451-474.
23. Groenewegen HJ, Berendse HW, Wouterlood FG. Organization of the projections from the ventral striato-pallidal system to ventral mesencephalic dopaminergic neurons in the rat. In: Percheron G, McKenzie JS, Feger J, eds. The basal ganglia IV: new ideas and data on structure and function. New York: Plenum Press; 1994:81-93.
24. Haber SN, Lynd E, Klein C, Groenewegen HJ. Topographic organization of the ventral striatal efferent projections in the rhesus monkey: an anterograde tracing study. J Comp Neurol 1990;293: 282-298.
25. Haber SN, Lynd-Balta E, Spooren WPJM. Integrative aspects of basal ganglia circuitry. In: Percheron G, McKenzie JS, Feger J, eds. The basal ganglia IV: new ideas and data on structure and function. New York: Plenum Press; 1994:71-80.
26. Hedreen JC, DeLong MR. Organization of striatopallidal, striatonigral, and nigrostriatal projections in the macaque. J Comp Neurol 1991;304:569-595.
27. Jimenez-Castellanos J, Graybiel AM. Subdivisions of the dopamine-containing A8-A9-A10 complex identified by their differential mesostriatal innervation of striosomes and extrastriosomal matrix. Neuroscience 1987;23:223-243.
28. Jimenez-Castellanos J, Graybiel AM. Evidence that histochemically distinct zones of the primate substantia nigra pars compacta are related to patterned distributions of nigrostriatal projection neurons and striatonigral fibers. Exp Brain Res 1989;74:227-238.
29. Lynd-Balta E, Haber SN. The organization of midbrain projections to the ventral striatum in the primate. Neuroscience 1994; 59:609-623.
30. Lynd-Balta E, Haber SN. The organization of midbrain projections to the striatum in the primate: sensorimotor-related striatum versus ventral striatum. Neuroscience 1994;59:625-640.
31. Mogenson GJ, Jones DL, Yim CY. From motivation to action: functional interface between the limbic system and the motor system. Prog Neurobiol 1980;14:69-97.
32. Nauta WJH, Smith GP, Faull RLM, Domesick VB. Efferent connections and nigral afferents of the nucleus accumbens septi in the rat. Neuroscience 1978;3:385-401.
33. Parent A, Hazrati LN. Functional anatomy of the basal ganglia. 1. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Brain Res Rev 1995;20:91-127.
34. Swanson LW, Mogenson GJ. Neural mechanisms for the functional coupling of autonomic, endocrine and somatomotor responses in adaptive behavior. Brain Res Brain Res Rev 1981;3: 1-34.
35. Bevan MD, Smith AD, Bolam JP. The substantia nigra as a site of synaptic integration of functionally diverse information arising from the ventral pallidum and the globus pallidus in the rat. Neuroscience 1996;75:5-12.
36. Bevan MD, Clarke NP, Bolam JP. Synaptic integration of functionally diverse pallidal information in the entopeduncular nucleus and subthalamic nucleus in the rat. J Neurosci 1997;17: 308-324.
37. Groenewegen HJ, Galis-de Graaf Y, Smeets WJ. Integration and segregation of limbic cortico-striatal loops at the thalamic level: an experimental tracing study in rats. J Chem Neuroanat 1999; 16:167-185.
38. O'Donnell P, Lavin A, Enquist LW, Grace AA, Card P. Interconnected parallel circuits between rat nucleus accumbens and thalamus revealed by retrograde transynaptic transport of pseudorabies virus. J Neurosci 1997;17:2143-2167.
39. Shink E, Bevan MD, Bolam JP, Smith Y. The subthalamic nucleus and the external pallidum: two tightly interconnected structures that control the output of the basal ganglia in the monkey. Neuroscience 1996;73:335-357.
40. Smith Y, Bevan MD, Shink E, Bolam JP. Microcircuitry of the direct and indirect pathways of the basal ganglia. Neuroscience 1998;86:353-387.
41. Zahm DS, Williams E, Wohltmann C. Ventral striatopallidothalamic projection: IV. Relative involvements of neurochemically distinct subterritories in the ventral pallidum and adjacent parts of the rostroventral forebrain. J Comp Neurol 1996;364:340-362.
42. Zahm DS. Functional-anatomical implications of the nucleus accumbens core and shell subterritories. Ann N Y Acad Sci 1999; 877:113-128.
43. Albin RL, Young AB, Penney JB. The functional anatomy of disorders of the basal ganglia. Trends Neurosci 1995;18:63-64.
44. Chesselet MF, Delfs JM. Basal ganglia and movement disorders: an update. Trends Neurosci 1996;19:417-422.
45. Feger J. Updating the functional model of the basal ganglia. Trends Neurosci 1997;20:152-153.
46. Levy R, Hazrati LN, Herrero MT, et al. Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states. Neuroscience 1997;76:335-343.
47. Parent A, Cicchetti F. The current model of basal ganglia organization under scrutiny. Mov Disord 1998;13:199-202.
48. Parent A, Hazrati LN. Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res Brain Res Rev 1995;20:128-154.
49. Fedio P, Cox CS, Neophytides A, Conal-Frederick G, Chase TN. Neuropsychological profile of Huntington's disease: patients and those at risk. Ad Neurol 1979;23:239-255.
50. Folstein SE, Folstein MF, McHugh PR. Psychiatric syndromes in Huntington's disease. Ad Neurol 1979;23:281-289.
51. Wilson RS, Garron DC. Cognitive and affective aspects of Huntington's disease. Ad Neurol 1979;23:193-201.
52. Albin RL, Tagle DA. Genetics and molecular biology of Huntington's disease. Trends Neurosci 1995;18:11-14.
53. Vonsattel JP, DiFiglia M. Huntington disease. J Neuropathol Exp Neurol 1998;57:369-384.
54. Albin RL. Selective neurodegeneration in huntington's disease. Ann Neurol 1995;38:835-836.
55. DiFiglia M, Sapp E, Chase KO, et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 1997;277:1990-1993.
56. Hayden MR, Martin WRW, Stoessl AJ, et al. Positron emission tomography in the early diagnosis of Huntington's disease. Neurology 1986;36:888-894.
57. Kowall NM, Ferrante RJ, Martin JB. Patterns of cell loss in Huntington's disease. Trends Neurosci 1987;10:24-29.
58. Mazziotta JC, Phelps ME, Pahl JJ, et al. Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease. New Engl J Med 1987;316:357-362.
59. Vonsattel J-P, Myers RH, Stevens TJ, et al. Huntington's disease: neuropathological grading. In: Carpenter MB, Jayaraman A, eds. The basal ganglia II: structure and function-current concepts. New York: Plenum Press; 1987:515-531.
60. Waters CM, Peck R, Rossor M, Reynolds GP, Hunt SP. Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea. Neuroscience 1988;25:419-438.
61. Young AB, Penney JB, Starosta-Rubinstein S, et al. PET scan investigations of Huntington's disease: cerebelar metabolic correlates of neurological features and functional decline. Ann Neurol 1986;20:296-303.
62. Augood SJ, Faull RL, Love DR, Emson PC. Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: a detailed cellular in situ hybridization study. Neuroscience 1996;72:1023-1036.
63. Ferrante RJ, Kowall NW, Richardson EO, Bird ED, Martin JB. Topography of enkephalin, substance P and acetylcholinesterase staining in Huntington's disease striatum. Neurosci Lett 1986;71: 283-288.
64. Hedreen JC, Folstein SE. Early loss of neostriatal striosome neurons in Huntington's disease. J Neuropathol Exp Neurol 1995; 54:105-120.
65. Richfield EK, Maguire-Zeiss KA, Vonkeman HE, Voorn P. Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients. Ann Neurol 1995;38:852-861.
66. Bamford KA, Caine ED, Kido DK, Plassche WM, Shoulson I. Clinical-pathologic correlation in Huntington's disease: a neuropsychological and computed tomography study. Neurology 1989; 39:796-801.
67. Bartenstein P, Weindl A, Spiegel S, et al. Central motor processing in huntington's disease. A PET study. Brain 1997;120:1553-1567.
68. Grafton ST, Mazziotta JC, Pahl JJ, et al. Serial changes of cerebral glucose metabolism and caudate size in persons at risk for Huntington's disease. Arch Neurol 1992;49:1161-1167.
69. Starkstein SE, Brandt J, Folstein S, Strauss M, McDonnell A, Folstein M. Brain atrophy in Huntington's disease: correlations with clinical and neuropsychological findings. Neurology 1988;38(Suppl 1):359.
70. Weinberger DR, Berman KF, Iadarola M, Driesen N, Zec, R. Prefrontal cortical blood flow and cognitive function in Huntington's disease. J Neurol Neurosurg Psychiatry 1988;52:94-104.
71. Aylward EH, Brandt J, Codori AM, Mangus RS, Barta PE, Harris GJ. Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons. Neurology 1994;44:823-828.
72. Aylward EH, Codori AM, Barta PE, Pearlson GD, Harris GJ, Brandt J. Basal ganglia volume and proximity to onset in presymptomatic Huntington disease. Arch Neurol 1996;53:1293-1296.
73. Antonini A, Leenders KL, Spiegel R, et al. Striatal glucose metabolism and dopamine d-2 receptor binding in asymptomatic gene carriers and patients with huntington's disease. Brain 1996; 119:2085-2095.
74. Ginovart N, Lundin A, Farde L, et al. PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease. Brain 1997;120:503-514.
75. Harris GJ, Pearlson GD, Peyser CE, et al. Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's disease. Ann Neurol 1992;31:69-75.
76. Harris GJ, Aylward EH, Peyser CE, et al. Single photon emission computed tomographic blood flow and magnetic resonance volume imaging of basal ganglia in Huntington's disease. Arch Neurol 1996;53:316-324.
77. Kuwert T, Lange HW, Langen KJ, Herzog H, Aulich A, Feinendegen LE. Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease. Brain 1990;113:1405-1423.
78. Pahl JJ, Mazziotta JC, Bartzokis G, et al. Metabolic dysfunction in tardive dyskinesia and Huntington's disease. Neurology 1988;38(Suppl 1):361.
79. Fenske T, Martin WRW, Ammann W, Clark C, Hayden MR. Specificity of cerebral metabolic abnormalities in Huntington's disease. Neurology 1988;38(Suppl 1):359.
80. Hasselbalch SG, Oberg G, Sorensen SA, et al. Reduced regional cerebral blood flow in Huntington's disease studied by SPECT. J Neurol Neurosurg Psychiatry 1992;55:1018-1023.
81. Backman L, Robbins-Wahlin T-B, Lundin A, Ginovart N, Farde L. Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes. Brain 1997;120: 2207-2217.
82. Lawrence AD, Weeks RA, Brooks DJ, et al. The relationship between striatal dopamine receptor binding and cognitive performance in Huntington's disease. Brain 1998;121:1343-1355.
83. Turjanski N, Weeks R, Dolan R, Harding AE, Brooks DJ. Striatal D1 and D2 receptor binding in patients with Huntington's disease and other choreas. Brain 1995;118:689-696.
84. Weeks RA, Piccini P, Harding AE, Brooks DJ. Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease. Ann Neurol 1996;40:49-54.
85. Albin RL, Reiner A, Anderson KD, Penney JB, Young AB. Striatal and nigral neuron subpopulations in rigid Huntington's disease: implications for the functional anatomy of chorea and rigidity-akinesia. Ann Neurol 1990;27:357-365.
86. Albin RL, Young AB, Penney JB, et al. Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease. New Engl J Med 1990;322: 1293-1298.
87. Pearson SJ, Heathfield KW, Reynolds GP. Pallidal GABA and chorea in Huntington's disease. J Neural Transm Gen Sect 1990; 81:241-246.
88. Reiner A, Albin RL, Anderson KD, D'Amato CJ, Penney JB, Young AB. Differential loss of striatal projection neurons in Huntington's disease. Proc Natl Acad Sci USA 1988;85:5733-5737.
89. Richfield EK, Herkenham M. Selective vulnerability in huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus. Ann Neurol 1994;36:577-584.
90. Sapp E, Ge P, Aizawa H, et al. Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis. Neuroscience 1995;64:397-404.
91. Storey E, Beal MF. Neurochemical substrates of rigidity and chorea in Huntington's disease. Brain 1993;116:1201-1222.
92. Ferrante RJ, Beal MF, Kowall NW. Mechanisms of neural degeneration in Huntington's disease. In: Percheron G, McKenzie JS, Feger J, eds. The basal ganglia IV: new ideas and data on structure and function. New York: Plenum Press; 1994:149-161.
93. Gerfen CR, Wilson CJ. The basal ganglia. In: Swanson LW, Bjorklumd A, Hokfelt T, editors. Handbook of chemical neuroanatomy. Amsterdam: Elsevier Science B.V.; 1996:371-468.
94. Reiner A, Anderson KD. The patterns of neurotransmitter and neuropeptide co-occurrence among striatal projection neurons: conclusions based on recent findings. Brain Res Brain Res Rev 1990;15:251-265.
95. Brandt J, Butters N. The neuropsychology of Huntington's disease. Trends Neurosci 1986;9:118-120.
96. Cummings JL. Frontal-subcortical circuits and human behavior. Arch Neurol 1993;50:873-880.
97. Sprengelmeyer R, Lange H, Homberg V. The pattern of attentional deficits in Huntington's disease. Brain 1995;118:145-152.
98. Bhatia KP, Marsden CD. The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain 1994; 117:859-876.
99. Mitchell IJ, Jackson A, Sambrook MA, Crossman AR. The role of the subthalamic nucleus in experimental chorea. Brain Res 1989; 112:1533-1548.
100. Mitchell IJ, Brotchie JM, Graham WC, et al. Advances in the understanding of neural mechanisms in movement disorders. In: Bernardi G, Carpenter MB, Di Chiara G, Morelli M, Stanzione P, eds. The basal ganglia III. New York: Plenum Press; 1991:607-616.
101. Litvan I, Paulsen JS, Mega MS, Cummings JL. Neuropsychiatric assessment of patients with hyperkinetic and hypokinetic movement disorders. Arch Neurol 1998;55:1313-1319.
102. Aldridge JW, Jeager D, Gilman S. A comparison of single unit activity in primate caudate nucleus and putamen in a sensory cued motor task. In: Bernardi G, Carpenter MB, Di Chiara G, Morelli M, Stanzione P, eds. The basal ganglia III. New York: Plenum Press; 1991:303-310.
103. Brotchie P, Iansek R, Horne MK. Motor function of the monkey globus pallidus: neuronal discharge and parameters of movement. Brain 1991;114:1667-1683.
104. Brotchie P, Iansek R, Horne MK. Motor function of the monkey globus pallidus: cognitive aspects of movement and phasic neuronal activity. Brain 1991;114:1685-1702.
105. Hikosaka O. Basal ganglia - possible role in motor coordination and learning. Cur Opin Neurobiol 1991;1:638-643.
106. Kimura M. The putamen neuron: activity and the association of a sensory stimulus with movement in the monkey. In: Carpenter MB, Jayaraman A, eds. The basal ganglia II: structure and function-current concepts. New York: Planum Press; 1987:337-347.
107. Lidsky TI, Manetto C, Schneider JS. A consideration of sensory factors involved in motor functions of the basal ganglia. Brain Res 1985;356:133-146.
108. Mink JW, Thach WT. Basal ganglia motor control. I. Nonexclusive relation of pallidal discharge to five movement modes. J Neurophysiol 1991;65:273-300.
109. Mink JW, Thach WT. Basal ganglia motor control. II. Late pallidal timing relative to movement onset and inconsistent pallidal coding of movement parameters. J Neurophysiol 1991;65:301-329.
110. Mink JW, Thach WT. Basal ganglia motor control. III. Pallidal ablation: normal reaction time, muscle cocontraction, and slow movement. J Neurophysiol 1991;65:330-351.
111. Nambu A, Yoshida S, Jinnai K. Discharge pattern of pallidal neurons with input from various cortical areas during movement in the monkey. Brain Res 1990;519:183-191.
112. Robbins TW, Brown VJ. The role of the striatum in the mental chronometry of action: a theoretical review. Rev Neurosci 1990; 2:181-213.
113. Rolls ET, Johnstone S. Neurophysiological analysis of striatal function. In: Wallesch C, Vallar G, eds. Neuropsychological disorders with subcortical lesions. Oxford: University Press; 1992: 61-97.
114. Rolls ET, Williams GV. Sensory and movement-related neuronal activity in different regions of the primate striatum. In: Schneider JS, Lidsky TT, eds. Basal ganglia and behavior: sensory aspects and motor functioning. Bern: Hans Huber; 1987:p 37-59.
115. Trouche E, Viallet F, Apicella P, Alamy M, Pons J-C, Legallet E. Pallidal and nigral hypokinesia: an experimental analysis in the monkey. In: Percheron G, McKenzie JS, Feger J, eds. The basal ganglia IV: new ideas and data on structure and function. New York: Penum Press; 1994:337-348.
116. Gabrieli J. Contribution of the basal gnaglia to skill learning and working memory in humans. In: Houk JC, Davis JL, Beiser DG, eds. Models of information processing in the basal ganglia. Cambridge: MIT Press; 1995:277-294.
117. Graybiel AM, Aosaki T, Flaherty AW, Kimura M. The basal ganglia and adaptive motor control. Science 1994;265:1826-1831.
118. Hikosaka O. Role of basal ganglia in control of innate movements, learned behavior and cognition. In: Percheron G, McKenzie JS, Feger J, eds. The basal ganglia IV: new ideas and data on structure and function. New York: Penum Press; 1994:589-596.
119. Joel D, Weiner I. Striatal contention scheduling and the split circuit scheme of basal ganglia-thalamocortical circuitry: From anatomy to behaviour. In: Miller R, Wickens JR, eds. Conceptual advances in brain research: brain dynamics and the striatal complex. Amsterdam: Harwood Academic Publishers; 1999:209-236.
120. Feger J, Mouroux M, Benazzouz A, Boraud T, Gross C, Crossman AR. The subthalamic nucleus: a more complex structure than expected. In: Percheron G, McKenzie JS, Feger J, eds. The basal ganglia IV: new ideas and data on structure and function. New York: Plenum Press; 1994:371-382.
121. Obeso JA, Guridi J, Herrero M-T. Role of the subthalamic nucleus in normal and pathological conditions. In: Percheron G, McKenzie JS, Feger J, eds. The basal ganglia IV: new ideas and data on structure and function. New York: Plenum Press; 1994: 365-370.
122. Smith Y, Wichmann T, DeLong MR. The external pallidum and the subthalamic nucleus send convergent synaptic inputs onto single neurons in the internal pallidal segment in monkey: anatomical organization and functional significance. In: Percheron G, McKenzie JS, Feger J, editors. The basal ganglia IV: new ideas and data on structure and function. New York: Plenum Press; 1994:51-62.
123. Wichman T, Bergman H, DeLong MR. The primate subthalamic nucleus. I. Functional properties in intact animals. J Neurophysiol 1994;72:494-506.
124. Matsumura M, Kojima J, Gardiner TW, Hikosaka O. Visual and oculomotor functions of monkey subthalamic nucleus. J Neurophysiol 1992;67:1615-1632.
125. Martin JB. Huntington's disease: new approaches to an old problem. Neurology 1984;34:1059-1072.
126. Martin JB, Gusella JF. Huntington's disease: pathogenesis and management. New Engl J Med 1986;315:1267-1276.
127. Penney JB, Young AB, Shoulson I, et al. Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals. Mov Disord 1990;5:93-99.
128. Aziz TZ, Peggs D, Sambrook MA, Crossman AR. Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate. Mov Disord 1991;1:288-292.
129. Crossman AR. Primate models of dyskinesia: the experimental approach to the study of basal ganglia-realted involuntary movement disorders. Neuroscience 1987;21:1-40.
130. DeLong MR. Primate models of movement diorders of basal ganglia origin. Trends Neurosci 1990;13:281-285.
131. Emerich DF, Sanberg PR. Animal models of Huntington's disease. In: Boulton AA, Baker GB, Butterworth RF, eds. Neuromothods 21: animal models of neurological disease, I. Neurodegenerative diseases. New Jersey: Humana Press; 1992:65-134.
132. Graham WC, Robertson RG, Aziz TZ, et al. The role of the internal segment of the globus pallidus in mediating dyskinesia. In: Percheron G, McKenzie JS, Feger J, eds. The basal ganglia IV: new ideas and data on structure and function. New York: Plenum Press; 1994:349-355.
133. Brown RG, Jahanshahi M. Cognitive-motor dysfunction in parkinson's disease. Eur Neurol 1996;36(Suppl 1):24-31.
134. Suchowersky O, Hayden MR, Martin WR, Stoessl AJ, Hildebrand AM, Pate BD. Cerebral metabolism of glucose in benign hereditary chorea. Mov Disord 1986;1:33-44.
135. Agostino R, Berardelli A, Formica A, Accornero N, Manfredi M. Sequential arm movements in patients with parkinson's disease, Huntington's disease and dystonia. Brain 1993;115:1481-1495.
136. Bradshaw JL, Phillips JG, Dennis C, et al. Initiation and execution of movement sequences in those suffering from and at-risk of developing Huntington's disease. J Clin Exp Neuropsychol 1992; 14:179-92.
137. Brown RG, Jahanshahi M, Marsden CD. The executation of bimanual movements in patients with parkinson's, Huntington's and cerebellar disease. J Neurol Neurosurg Psychiatry 1993;56: 295-297.
138. Georgiou N, Bradshaw JL, Phillips JG, Chiu E, Bradshaw JA. Reliance on advance information and movement sequencing in Huntington's disease. Mov Disord 1995;10:472-481.
139. Georgiou N, Phillips JG, Bradshaw JL, Cunnington R, Chiu E. Impairments of movement kinematics in patients with Huntington's disease: a comparison with and without a concurrent task. Mov Disord 1997;12:386-396.
140. Hefter H, Homberg V, Lange HW, Freund H-J. Impairment of rapid movement in Huntington's disease. Brain 1987;110:585-612.
141. Jahanshahi M, Brown RG, Marsden CD. A comparative study of simple and choice reaction time in Parkinson's, Huntington's and cerebellar disease. J Neurol Neurosurg Psychiatry 1993;56:1169-1177.
142. Phillips JG, Bradshaw JL, Chiu E, Bradshaw JA. Characteristics of handwriting of patients with Huntington's disease. Mov Disord 1994;9:521-530.
143. Stelmach GE, Phillips JG. Movement disorders-limb movement and the basal ganglia. Phys Ther 1991;71:60-67.
144. Thompson PD, Berardelli A, Rothwell JC, et al. The coexistence of bradykinesia and chorea in Huntington's disease and its implications for theories of basal ganglia control of movement. Brain 1988;111:223-244.
145. Baroni A, Benvenuti F, Fantini L, Pantaleo T, Urbani F. Human ballistic arm abduction movements: effects of L-dopa treatment in Parkinson's disease. Neurology 1984;34:868-876.
146. Berardelli A, Accornero N, Argenta M, Meco G, Manfredi M. Fast complex arm movements in Parkinson's disease. J Neurol Neurosurg Psychiatry 1986;49:1146-1149.
147. Hallett M, Shahani BT, Young RR. Analysis of stereotyped voluntary movements at the elbow in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1977;40:1129-1135.
148. Hallett M, Khoshbin S. A physiological mechanism of bradykinesia. Brain 1980;103:301-314.
149. Phillips JG, Stelmach GE, Teasdale N. What can indices of handwriting quality tell us about parkinsonian handwriting? Human Movement Science 1991;10:301-314.
150. Oertel WH, Quinn NP. Parkinsonism-movement disorders. Neurological disorders: course and treatment. San Diego: Academic Press; 1996.
151. Georgiou N, Bradshaw JL, Iansek R, Phillips JG, Mattingley JB, Bradshaw JA. Reduction in external cues and movement sequencing in Parkinson's disease. J Neurol Neurosurg Psychiatry 1994; 57:368-370.
152. Georgiou N, Bradshaw JL, Phillips JG, Bradshaw JA, Chiu E. The simon effect and attention deficits in gilles de la tourette's syndrome and huntington's disease. Brain 1995;118:1305-1318.
153. Jones DL, Phillips JG, Bradshaw JL, Iansek R, Bradshaw JA. Programming of single movements in Parkinson's disease: comparison with Huntington's disease. J Clin Exp Neuropsychol 1992;14:762-772.
154. Brown RG, Marsden CD. Cognitive function in Parkinson's disease: from description to theory. Trends Neurosci 1990;13:21-29.
155. Butters N, Albert MS, Sax D. Investigations of the memory disorders of patients with Huntington's disease. Adv Neurol 1979; 23:203-213.
156. Savage CR. Neuropsychology of subcortical dementias. Psychiatr Clin North Am 1997;20:911-931.
157. Saint-Cyr JA, Taylor AE, Lang AE. Procedural learning and neostriatal dysfunction in man. Brain 1988;111:941-959.
158. Sprengelmeyer R, Canavan AG, Lange HW, Homberg V. Associative learning in degenerative neostriatal disorders: contrasts in explicit and implicit remembering between Parkinson's and Huntington's diseases. Mov Disord 1995;10:51-65.
159. Owen AM, James M, Leigh PN, et al. Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain 1992; 115:1727-1751.
160. Hanes KR, Andrewes DG, Pantelis C, Chiu E. Subcortical dysfunction in schizophrenia: a comparison with Parkinson's disease and Huntington's disease. Schizophr Res 1996;19:121-128.
161. Lundervold AJ, Karlsen NR, Reinvang I. Assessment of 'subcortical dementia' in patients with Huntington's disease, Parkinson's disease, multiple sclerosis and AIDS by a neuropsychological screening battery. Scand J Psychol 1994;35:48-55.
162. Pillon B, Dubois B, Ploska A, Agid Y. Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy. Neurology 1991;41:634-643.
163. Pillon B, Deweer B, Agid Y, Dubois B. Explicit memory in Alzheimer's, Huntington's, and Parkinson's diseases. Arch Neurol 1993;50:374-379.
164. Weingartner H, Caine ED, Ebert MH. Imagery, encoding, and retrieval of information from memory: some specific encoding-retrieval changes in Huntington's disease. J Abnorm Psychol 1979;88:52-58.
165. Beatty WW. Remote memory for visuospatial information in patients with Huntington's disease. Psychobiology 1989;17:431-434.
166. Cools AR, van den Bercken JHL, Horstink MWI, van Spandonck KPM, Berger HJC. Cognitive and motor shifting aptitude disorder in Parkinson's disease. J Neurol Neuros Psychiatry 1984;47: 443-453.
167. Cooper JA, Sagar HJ, Doherty SM, Jordan N, Tidswell P, Sullivan EV. Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease - a follow-up study of untreated patients. Brain 1992;115: 1701-1725.
168. Goldberg TE, Berman KF, Mohr E, Weinberger DR. Regional cerebral blood flow and cognitive function in Huntington's disease and schizophrenia. A comparison of patients matched for performance on a prefrontal-type task. Arch Neurol 1990;47:418-422.
169. Josiassen RC, Curry LM, Mancall EL. Development of neuropsychological deficits in Huntington's disease. Arch Neurol 1983;40:791-796.
170. Lund-Johansen M, Hugdahl K, Wester K. Cognitive function in patients with Parkinson's disease undergoing stereotaxic thalamotomy. J Neurol Neurosurg Psychiatry 1996;60:564-571.
171. Zappacosta B, Monza D, Meoni C, et al. Psychiatric symptoms do not correlate with cognitive decline, motor symptoms, or CAG repeat length in Huntington's disease. Arch Neurol 1996;53:493-497.
172. Hanes KR, Andrewes DG, Pantelis C. Cognitive flexibility and complex integration in Parkinson's disease, Huntington's disease, and schizophrenia. J Int Neuropsychol Soc 1995;1:545-553.
173. Cope MT, Georgiou N, Bradshaw JL, Iansek R, Phillips JG. Simon effect and attention in Parkinson's disease: a comparison with Huntington's disease and Tourette's syndrome. J Clin Exp Neuropsychol 1996;18:276-290.
174. Lasker AG, Zee DS. Ocular motor abnormalities in Huntington's disease. Vision Res 1997;37:3639-3645.
175. Avanzini G, Girotti F, Caraceni T, Spreafico R. Oculomotor disorders in Huntington's chorea. J Neurol Neurosurg Psychiatry 1979;42:581-589.
176. Kennard C, Lueck CJ. Oculomotor abnormalities in diseases of the basal ganglia. Rev Neurol 1989;145:587-595.
177. Lasker AG, Zee DS, Hain TC, Folstein SE, Singer HS. Saccades in Huntington's disease: initiation defects and distractibility. Neurology 1987;37:364-370.
178. Lasker AG, Zee DS, Hain TC, Folstein SE, Singer HS. Saccades in Huntington's disease: slowing and dysmetria. Neurology 1988; 38:427-431.
179. Leigh RJ, Newman SA, Folstein SE, Lasker AG, Jensen BA. Abnormal ocular motor control in Huntington's disease. Neurology 1983;33:1268-1275.
180. Tian JR, Zee DS, Lasker AG, Folstein SE. Saccades in Huntington's disease: predictive tracking and interaction between release of fixation and initiation of saccades. Neurology 1991;41:875-881.
181. Hikosaka O. Role of basal ganglia in saccades. Rev Neurol Paris 1989;145:580-586.
182. Lueck CJ, Tanyeri S, Crawford TJ, Henderson L, Kennard C. Antisaccades and remembered saccades in Parkinson's disease. J Neurol Neurosurg Psychiatry 1990;53:284-288.
183. Lueck CJ, Tanyeri S, Crawford TJ, Henderson L, Kennard C. Saccadic eye movements in Parkinson's disease: I. Delayed saccades. Q J Exp Psychol. [A] 1992;45:193-210.
184. Lueck CJ, Crawford TJ, Henderson L, Van Gisbergen JA, Duysens J, Kennard C. Saccadic eye movements in Parkinson's disease: II. Remembered saccades - towards a unified hypothesis? Q J Exp Psychol [A] 1992;45:211-233.
185. Yamaguchi S, Kobayashi S. Contributions of the dopaminergic system to voluntary and automatic orienting of visuospatial attention. J Neurosci 1998;18:1869-1878.
186. Fukushima J, Fukushima K, Miyasaka K, Yamashita I. Voluntary control of saccadic eye movement in patients with frontal cortical lesions and parkinsonian patients in comparison with that in schizophrenics. Biol Psychiatry 1994;36:21-30.
187. Kitagawa M, Fukushima J, Tashiro K. Relationship between antisaccades and the clinical symptoms in Parkinson's disease. Neurology 1994;44:2285-2289.
188. Vidailhet M, Rivaud S, Gouider-Khouja N, et al. Eye movements in parkinsonian syndromes. Ann Neurol 1994;35:420-426.
189. Posner MI. Attention: the mechanisms of consciousness. Proc Natl Acad Sci USA 1994;91:7398-7403.
190. Posner MI, Dehaene S. Attentional networks. Trends Neurosci 1994;17:75-79.
191. Rizzolatti G, Riggio L, Sheliga BM. Space and selective attention. In: Umilta C, Moscovitch M, eds. Attention and performance XV. Conscious and nonconscious information processing. Cambridge: A Bradford Book, MIT Press; 1994:231-265.
192. Georgiou N, Bradshaw JL, Phillips JG, Chiu E. The effect of Huntington's disease and Gilles de la Tourette's syndrome on the ability to hold and shift attention. Neuropsychologia 1996;34: 843-851.
193. Caine ED, Shoulson I. Psychiatric syndromes in Huntington's disease. Am J Psychiatry 1983;140:728-733.
194. Cummings JL, Cunningham K. Obsessive-compulsive disorder in Huntington's disease. Biol Psychiatry 1992;31:263-270.
195. De Marchi N, Morris M, Mennella R, Lapia S, Nestadt G. Association of obsessive-compulsive disorder and pathological gambling with huntington's disease in an Italian pedigree: possible association with huntington's disease mutation. Acta Psychiatr Scand 1998;97:62-65.
196. Shoulson I. Huntington disease: functional capacities in patients treated with neuroleptic and antidepressant drugs. Neurology 1981;31:1333-1335.
197. Williamson PC, Malla A, Cortese L, Stoessl AJ, Drost D, Stanley JA. Phosphorus 31 magnetic resonance spectroscopy in patients with huntington disease. Arch Gen Psychiatry 1997;54:186-187.
198. Eslinger PJ, Damasio AR. Severe disturbances of higher cognition after bilateral frontal lobe ablation: patient EVR. Neurology 1985;35:1731-1741.
199. Kolb B, Whishaw IQ. Fundamentals of human neuropsychology. New York: W.H. Freeman and Company; 1990.
200. Laplane D, Levasseur M, Pillon B, et al. Obsessive-compulsive and other behavioural changes with bilateral basal ganglia lesions. A neuropsychological, magnetic resonance imaging and positron tomography study. Brain 1989;112:699-725.
201. Caine ED, Ebert MH, Weingartner H. An outline for the analysis of dementia. The memory disorder of Huntingtons disease. Neurology 1977;27:1087-1092.
202. Whittier J. Hereditary chorea (Huntington's chorea): A paradigm of brain dysfunction with psychopathology. In: Suagass C, Gersuon S, Frieduoff A, eds. Psychopathology and brain dysfunction. New York: Raven Press; 1977:267-277.
203. Aizawa H, Kwak S, Shimizu T, et al. A case of adult onset pure pallidal degeneration. I. Clinical manifestations and neuropathological observations. J Neurol Sci 1991;102:76-82.
204. Beal MF, Kowall NW, Ellison DW, Mazurek MF, Swartz KJ, Martin JB. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 1986;321:168-171.
205. Ellison DW, Beal MF, Mazurek MF, Malloy JR, Bird ED, Martin JB. Amino acid neurotransmitter abnormalities in Huntington's disease and the quinolinic acid animal model of Huntington's disease. Brain 1987;110:1657-1673.
206. Roberts RC, Ahn A, Swartz KJ, Beal MF, DiFiglia M. Intrastriatal injections of quinolinic acid or kainic acid: differential patterns of cell survival and the effects of data analysis on outcome. Exp Neurol 1993;124:274-282.
207. Joel D, Ayalon L, Tarrasch R, Veenman L, Feldon J, Weiner I. Electrolytic lesion of globus pallidus ameliorates the behavioral and neurodegenerative effects of quinolinic acid lesion of the striatum: a potential novel treatment in a rat model of Huntington's disease. Brain Res 1998;787:143-148.